TNXP:Tonix Pharmaceuticals Holding Corp * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$0.16 NASDAQ 4:15p ET
April 1 '24 		Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highligh... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
     GlobeNewswire
    Full Story →

    Headline News
    Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
    9:33a ET March 28 '24 GlobeNewswire
    Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
    8:00a ET March 25 '24 GlobeNewswire
    Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
    8:00a ET March 21 '24 GlobeNewswire
    More News →
    Day  0.90%Week  4.60%Month  54.68%More Charting →
    April 23 '24. Markets Closed.
    Last $0.16
    Day change   0.90%$0.00
    Open $0.1548
    Gap at open $0.00
    Previous close $0.16
    Trading volume 1,588,870
    10 Day avg vol. 2,796,234
    Shares out. 84.5Mil
    Market cap. $13.2Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 22 '24.

    Historical Price Performance
    3 month   44.40% 
    6 month   71.49% 
    1 year   94.67% 
    2 year   99.50% 

    Earnings
    Previous 12m -$8.62
    Next 12m Estimate -$1.57
    P/E ratio NM
    Revenue 8Mil
    NM = Not Meaningful

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.